RGD-modified angiogenesis inhibitor HM-3 dose: dual function during cancer treatment

Hanmei Xu1, Li Pan, Yinling Ren

  • 1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China. xuhanmei@cpu.edu.cn